This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Allerject (2015-06-13)

Starting date:
June 13, 2015
Posting date:
June 16, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-53819

Recalled Products

Allerject

Reason

Potential device defect affecting delivery of drug to patient.

Depth of distribution

Retailers

Affected products

Allerject

DIN, NPN, DIN-HIM

DIN 02382059

Dosage form

Solution

Strength

Epinephrine 0.15 mg / 0.15 mL

Lot or serial number
  • 2857505
  • 2857508
Companies
Recalling Firm

Sanofi-Aventis Canada Inc.

2905 Place Louis.R-Renaud

Laval

H7V 0A3

Quebec

CANADA

Marketing Authorization Holder

Sanofi-Aventis Canada Inc.

2905 Place Louis.R-Renaud

Laval

H7V 0A3

Quebec

CANADA



Two Lots of Allerject (0.15 mg / 0.15mL auto-injector) For Use In Children Recalled Due to Manufacturing Defect

2015-06-13 | Health products

Advisory


Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: